305 related articles for article (PubMed ID: 23566831)
1. Therapeutic angiogenesis for revascularization in peripheral artery disease.
Grochot-Przeczek A; Dulak J; Jozkowicz A
Gene; 2013 Aug; 525(2):220-8. PubMed ID: 23566831
[TBL] [Abstract][Full Text] [Related]
2. The therapeutic effect of vascular endothelial growth factor gene- or heme oxygenase-1 gene-modified endothelial progenitor cells on neovascularization of rat hindlimb ischemia model.
Long J; Wang S; Zhang Y; Liu X; Zhang H; Wang S
J Vasc Surg; 2013 Sep; 58(3):756-65.e2. PubMed ID: 23562340
[TBL] [Abstract][Full Text] [Related]
3. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
Gacche RN; Meshram RJ
Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
[TBL] [Abstract][Full Text] [Related]
4. Combination of stromal-derived factor-1alpha and vascular endothelial growth factor gene-modified endothelial progenitor cells is more effective for ischemic neovascularization.
Yu JX; Huang XF; Lv WM; Ye CS; Peng XZ; Zhang H; Xiao LB; Wang SM
J Vasc Surg; 2009 Sep; 50(3):608-16. PubMed ID: 19595531
[TBL] [Abstract][Full Text] [Related]
5. Stromal cell-derived factor and granulocyte-monocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy.
Woo YJ; Grand TJ; Berry MF; Atluri P; Moise MA; Hsu VM; Cohen J; Fisher O; Burdick J; Taylor M; Zentko S; Liao G; Smith M; Kolakowski S; Jayasankar V; Gardner TJ; Sweeney HL
J Thorac Cardiovasc Surg; 2005 Aug; 130(2):321-9. PubMed ID: 16077394
[TBL] [Abstract][Full Text] [Related]
6. Gene therapy for peripheral arterial disease.
Shimamura M; Nakagami H; Taniyama Y; Morishita R
Expert Opin Biol Ther; 2014 Aug; 14(8):1175-84. PubMed ID: 24766232
[TBL] [Abstract][Full Text] [Related]
7. Ang-1 gene therapy inhibits hypoxia-inducible factor-1alpha (HIF-1alpha)-prolyl-4-hydroxylase-2, stabilizes HIF-1alpha expression, and normalizes immature vasculature in db/db mice.
Chen JX; Stinnett A
Diabetes; 2008 Dec; 57(12):3335-43. PubMed ID: 18835934
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic angiogenesis: recent and future prospects of gene therapy in peripheral artery disease.
Tanaka M; Taketomi K; Yonemitsu Y
Curr Gene Ther; 2014; 14(4):300-8. PubMed ID: 25197884
[TBL] [Abstract][Full Text] [Related]
9. [Roles of heme oxygenase-1 promoting regeneration of peribiliary vascular plexus in bile duct ischemia/reperfusion injury].
Huang H; Hou M; Xu J; Pang T; Duan J; Li Z; Zeng Z; Wang K
Zhonghua Wai Ke Za Zhi; 2014 Mar; 52(3):193-7. PubMed ID: 24785458
[TBL] [Abstract][Full Text] [Related]
10. Gene therapy and cell-based therapies for therapeutic angiogenesis in peripheral artery disease.
Shimamura M; Nakagami H; Koriyama H; Morishita R
Biomed Res Int; 2013; 2013():186215. PubMed ID: 24294599
[TBL] [Abstract][Full Text] [Related]
11. Hepatocyte growth factor stimulated angiogenesis without inflammation: differential actions between hepatocyte growth factor, vascular endothelial growth factor and basic fibroblast growth factor.
Kaga T; Kawano H; Sakaguchi M; Nakazawa T; Taniyama Y; Morishita R
Vascul Pharmacol; 2012 Aug; 57(1):3-9. PubMed ID: 22361334
[TBL] [Abstract][Full Text] [Related]
12. Effects of combined mesenchymal stem cells and heme oxygenase-1 therapy on cardiac performance.
Zeng B; Chen H; Zhu C; Ren X; Lin G; Cao F
Eur J Cardiothorac Surg; 2008 Oct; 34(4):850-6. PubMed ID: 18640847
[TBL] [Abstract][Full Text] [Related]
13. Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization.
Hiasa K; Ishibashi M; Ohtani K; Inoue S; Zhao Q; Kitamoto S; Sata M; Ichiki T; Takeshita A; Egashira K
Circulation; 2004 May; 109(20):2454-61. PubMed ID: 15148275
[TBL] [Abstract][Full Text] [Related]
14. Heme oxygenase-1 and carbon monoxide promote neovascularization after myocardial infarction by modulating the expression of HIF-1alpha, SDF-1alpha and VEGF-B.
Lakkisto P; Kytö V; Forsten H; Siren JM; Segersvärd H; Voipio-Pulkki LM; Laine M; Pulkki K; Tikkanen I
Eur J Pharmacol; 2010 Jun; 635(1-3):156-64. PubMed ID: 20303947
[TBL] [Abstract][Full Text] [Related]
15. Angiogenesis in peripheral arterial disease.
Inampudi C; Akintoye E; Ando T; Briasoulis A
Curr Opin Pharmacol; 2018 Apr; 39():60-67. PubMed ID: 29529399
[TBL] [Abstract][Full Text] [Related]
16. Heme oxygenase-1 promotes angiogenesis in urothelial carcinoma of the urinary bladder.
Miyake M; Fujimoto K; Anai S; Ohnishi S; Kuwada M; Nakai Y; Inoue T; Matsumura Y; Tomioka A; Ikeda T; Tanaka N; Hirao Y
Oncol Rep; 2011 Mar; 25(3):653-60. PubMed ID: 21206978
[TBL] [Abstract][Full Text] [Related]
17. Human adipose tissue-resident monocytes exhibit an endothelial-like phenotype and display angiogenic properties.
Navarro A; Marín S; Riol N; Carbonell-Uberos F; Miñana MD
Stem Cell Res Ther; 2014 Apr; 5(2):50. PubMed ID: 24731246
[TBL] [Abstract][Full Text] [Related]
18. Blood vessel formation in the tissue-engineered bone with the constitutively active form of HIF-1α mediated BMSCs.
Zou D; Zhang Z; He J; Zhang K; Ye D; Han W; Zhou J; Wang Y; Li Q; Liu X; Zhang X; Wang S; Hu J; Zhu C; Zhang W; zhou Y; Fu H; Huang Y; Jiang X
Biomaterials; 2012 Mar; 33(7):2097-108. PubMed ID: 22172336
[TBL] [Abstract][Full Text] [Related]
19. Gene therapy in peripheral artery disease.
Sanada F; Taniyama Y; Kanbara Y; Otsu R; Ikeda-Iwabu Y; Carracedo M; Rakugi H; Morishita R
Expert Opin Biol Ther; 2015 Mar; 15(3):381-90. PubMed ID: 25633211
[TBL] [Abstract][Full Text] [Related]
20. Granulocyte colony-stimulating factor and stromal cell-derived factor-1 combination therapy: A more effective treatment for cerebral ischemic stroke.
Wang ML; Zhang LX; Wei JJ; Li LL; Zhong WZ; Lin XJ; Zheng JO; Li XF
Int J Stroke; 2020 Oct; 15(7):743-754. PubMed ID: 31564240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
